Salesforce, Inc. (CRM) is a customer relationship management and enterprise cloud-software company, not an exchange-traded fund. Across the roughly 56 analyst price targets compiled in late October 2026, the arithmetic mean sits near $287, which rounds to a central stock price target of $290. The analyst price target range is unusually wide — from a cautious low near $195 to a Street-high of $400 — signaling that Wall Street is far from unanimous.
Named examples illustrate the split. Mizuho Securities analyst Gregg Moskowitz reiterated a Buy rating with a $350 target in early October 2026, while Cantor Fitzgerald maintained an Overweight rating and a $300 target. On the cautious side, a handful of firms carry targets well below the current price, arguing that Salesforce's growth is still decelerating despite headline beats. The bulk of coverage remains constructive, with a clear majority of ratings in the Buy or Strong Buy camp.
Because this figure is the average of many individual analyst targets rather than an independently published consensus, it should be read as a rough center of opinion — not a guarantee or a forecast. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
As of its most recent close near $229.17, reaching $290 would require upside of about 26%, which is a substantial move rather than a modest drift. The path would first require clearing the stock's 52-week high around $269, a level that has repeatedly acted as resistance, before extending toward $290.
Fundamentally, the company has posted solid results: quarterly revenue grew roughly 11% year over year, while net margin improved to around 31%, and the company announced a $5.66 billion acquisition of real-time marketing platform Braze to deepen its Marketing Cloud. Whether the stock can translate this into a sustained re-rating depends on re-accelerating organic growth and convincing evidence that the AI product cycle is expanding the revenue base rather than merely defending it.
The most important support is Agentforce, Salesforce's autonomous AI-agent platform, which has become the centerpiece of the bull case as enterprise adoption and usage metrics climb. Combined with the company's expanding margins, strong free cash flow, and ongoing share repurchases, this positions Salesforce as a beneficiary of the agentic-AI buildout in the enterprise.
The Braze acquisition, while costly, could broaden the marketing offering and accelerate cross-selling. Recent analyst activity has skewed positive, including upgrades and maintained Buy ratings that frame Salesforce as attractively valued after its pullback. A forward price-to-earnings (P/E) ratio in the mid-teens also leaves room for multiple expansion if growth re-accelerates.
The principal risk is that organic revenue growth continues to decelerate, and that AI-native competitors — including major AI labs and hyperscalers moving into enterprise applications — erode Salesforce's pricing power and seat-based economics. The Braze deal also introduces near-term integration costs and margin pressure, which some analysts cite as a drag on fiscal-year profitability.
Valuation compression is another hurdle: if investors conclude that AI agents reduce, rather than expand, software spending, the stock's multiple could contract even on stable earnings. The wide $195-to-$400 target range underscores that a meaningful minority of analysts expect the shares to move lower, not higher.
Technically, the shares sit below their 50-day moving average near $239 but above the 200-day moving average near $198, leaving the intermediate trend unsettled. The 52-week high near $269 is the most significant resistance level a move toward $290 would need to overcome. On the downside, support is visible near $220, with the $200 area and the 200-day average providing deeper cushions. A decisive break above $269 would be the clearest structural signal that a run toward $290 is underway. From what I see, monitoring these levels alongside AI-driven pattern tools can help clarify the setup.
Analyst price targets generally reflect a research horizon of roughly 12 months, though individual firms vary. Investors should monitor the next quarterly earnings report, guidance for organic (constant-currency) revenue growth, and margin commentary tied to the Braze integration. Also watch Agentforce adoption metrics, any analyst target revisions, and broader software-sector sentiment around AI monetization. A sustained move above the $269 prior high — or a breakdown below $200 — would meaningfully reshape the outlook. I’m watching this closely as earnings season approaches.
In my own analysis, Tickeron's AI Daily Buy/Sell Signals provide a useful layer by applying artificial intelligence to monitor thousands of stocks and generate Buy, Sell, or Hold signals based on technical behavior and market conditions. This helps surface opportunities and track shifts in names like Salesforce more systematically alongside fundamental work.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Stochastic Oscillator for CRM moved into oversold territory on October 30, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
Following a +3.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRM advanced for three days, in 222 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
CRM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRM as a result. In 58 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
The Moving Average Convergence Divergence Histogram (MACD) for CRM turned negative on October 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 33 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 66%.
CRM moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.
The Aroon Indicator for CRM entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. CRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.914) is normal, around the industry mean (-1.586). P/E Ratio (20.948) is within average values for comparable stocks, (15.399). Projected Growth (PEG Ratio) (0.759) is also within normal values, averaging (2.824). Dividend Yield (0.008) settles around the average of (0.073) among similar stocks. P/S Ratio (5.107) is also within normal values, averaging (70.854).
The Tickeron PE Growth Rating for this company is 86 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of on-demand customer relationship management software technology
Industry PackagedSoftware